![](/img/cover-not-exists.png)
Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial
Damaj, G., Gressin, R., Bouabdallah, K., Cartron, G., Choufi, B., Gyan, E., Banos, A., Jaccard, A., Park, S., Tournilhac, O., Schiano-de Collela, J.-M., Voillat, L., Joly, B., Le Gouill, S., Saad, A.,Volume:
31
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2012.43.7285
Date:
January, 2013
File:
PDF, 130 KB
english, 2013